Treatment of chronic back pain. Current approaches to pain management


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Chronic pain is one of the most challenging issues of modern neurology, which is caused by the widespread prevalence of pain syndrome accompanying various diseases, especially among the working age population, negatively affecting patients' quality of life. The pathophysiology of chronic pain has been well studied and a wide range of drugs is currently being used both for relief of acute pain and for the treatment of chronic pain. Nevertheless, there is a need for the use of analgesics with high analgesic activity, which are capable of providing a continuous analgesic effect, having a narrow spectrum of adverse effects and simple to use in practice. A powerful opioid analgesic fentanyl meets these requirements. For many years fentanyl TTS has been used primarily for relief of cancer chronic pain. Now the use of fentanyl TTS is increasingly considered for non-cancer chronic pain. This article presents the results of using fentanyl TTS for chronic vertebral pain syndrome and osteoarthritis.

全文:

受限制的访问

作者简介

Olga Kurushina

FGBOU VO «Volgograd State Medical University» of the Ministry of Health of Russia

Email: ovkurushina@mail.ru
MD, Professor of the Department of neurology, neurosurgery, medical genetics with a course in neurology, manual therapy and reflexotherapy FUV

Alexander Barulin

FGBOU VO «Volgograd State Medical University» of the Ministry of Health of Russia

Email: barulin23@mail.ru
MD, Professor of the Department of neurology, neurosurgery, medical genetics with a course in neurology, manual therapy and reflexotherapy FUV

Elena Chernovolenko

Volgograd State Medical University of the Ministry of Health of Russia

Email: chernovolenkoelena@rambler.ru
post-graduate student of the Department of neurology, neurosurgery, medical genetics with a course in neurology, manual therapy and reflexotherapy FUV

参考

  1. Барулин А.Е., Курушина О.В., Калинченко Б.М., Черноволенко Е.П. Хроническая боль и депрессия. Лекарственный вестник; 2016. Т. 10(1): с. 3-10. [Barulin A.E., Kurushina O.V., Kalinchenko B.M. Chronic pain and depression. Medicinal messenger, 2016. Т.10(1):3-10]
  2. Данилов А.Б. Биопсихосоциальная модель и хроническая боль. Российский журнал боли. 2010. № 1 (26). С. 3-7. [Danilov A.B. Biopsychosocial model and chronic pain. Russian Journal of Pain. 2010. № 1 (26):3-7]
  3. Курушина О.В., Барулин А.Е. Современные подходы к патогенетическому лечению дорсопатий: обзор клинических рекомендаций. РМЖ; 2013. Т. 21(10): 507-511 [Kurushina O.V., Barulin A.E. Modern approaches to pathogenetic treatment of dorsopathies: review of clinical recommendations. RMJ, 2013. Т. 21(10):507-51 1].
  4. Кукушкин М.Л. Хроническая боль. Неврология, нейропсихиатрия, психосоматика; 2010. № 3:80-86. [Kukushkin M.L. Chronic pain. Neurology, neuropsychiatry, psychosomatics 2010. № 3:80-86].
  5. Барулин А.Е., Курушина О.В., Черноволенко Е.П. Современный взгляд на лечение болей в спине. Лекарственный вестник; 2013. Т.7. № 1(49):7-13. [Barulin A.E., Kurushina O.V., Chernovolenko E.P. A modern aspects of back pain treatment. Medicinal messenger, 2013. Т.7. № 1(49):7-13].
  6. Пчелинцев М.В., Абузарова Г.Р. Трансдермальные терапевтические системы с фентанилом при хронической боли. Врач; 2011. № 6; 39-42. [Pchelintsev M.V., Abuzarova G.R. Transdermal therapeutic systems with fentanyl in chronic pain. Physician; 2011. № 6;39-42].
  7. Курушина О.В., Барулин А.Е., Гордеева И.Е., Ансаров Х.Ш., Черноволенко Е.П. Диагностика и лечение болевых синдромов при болезни Паркинсона. РМЖ; 2016. Т. 24(25):1715-1717. [Kurushina O.V., Barulin A.E., Gordeeva I.E., Ansarov H.S., Chernovolenko E.P. Diagnostics and treatment pain syndroms in Parkinson's disease. RMJ, 2016. Т. 24(25):1715-1717].
  8. Ананьева Л.П. Применение наркотических анальгетиков при лечении хронической неонкологической боли. РМЖ; 2008: 21. [Ananjeva L.P. The use of narcotic analgesics in the treatment of chronic non-cancer pain. RMJ; 2008:21].
  9. Барулин А.Е., Курушина О.В., Бабушкин Я.Х. Боли в спине: современные подходы к диагностике и лечению. Лекарственный вестник; 2009. Т. 5(4): 19-28. [Barulin A.E., Kurushina O.V., Babushkin J.H. Back pain: modern aspects of diagnostics and treatment. Medicinal messenger, 2009. Т. 5(4):19-28].
  10. J. Lee, J.S. Yoon, J.H. Lee, S. Chung, Kyu-Yeol Lee, Y.Y. Kim, J.M. Kim, M.H. Kong, U.G. Kang, Ye-Soo Park Clinical usefulness of long-term application of fentanyl improvement of pain and physical and emotional functions matrix in chronic non-cancer pain: Clin Orthop Surg. 2016. Dec; 8(4): 465-474.
  11. Muijsers R.B., Wagstaff A.J. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs. 2001;61(15):2289-2307.
  12. Noble M., Treadwell J.R., Tregear S.J. et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;(1).
  13. Porter J., Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980 Jan 10;302(2):123.
  14. Lindley E.M., Milligan K., Farmer R., Burger E.L., Patel V.V. Patient-controlled transdermal fentanyl versus intravenous morphine pump after spine surgery. Orthopedics. 2015; 38(9):e819-e824.
  15. Viscusi E.R., Grond S., Ding L., Danesi H., Jones J.B., Sinatra R.S. A comparison of opioid-related adverse events with fentanyl iontophoretic transdermal system versus morphine intravenous patient-controlled analgesia in acute postoperative pain. Pain Manag. 2016;6(1):19-24.
  16. Matsumoto S., Matsumoto K., Iida H. Transdermal fentanyl patch improves post-operative pain relief and promotes early functional recovery in patients undergoing primary total knee arthroplasty: a prospective, randomised, controlled trial. Arch Orthop Trauma Surg. 2015;135(9):1291-1297.
  17. Hosseini H., Kargar S., Shiryazdi S.M., Kargar S., Rezaie F., Neamatzadeh H. Fentanyl transdermal patch (Durogesic® DTRANS) for post abdominal laparotomy analgesia: a double blind randomized study. Minerva Chir. 2015;70(6):401-408.
  18. Yoo B.W., Kim J.H., Park Y.S. Effect of long-term treatment and efficacy of transdermal opioid patch in the chronic low back pain. Int J Pain. 2010;1:15-20.
  19. Allan L., Hays H., Jensen N.H. et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ. 2001;322(7295):1154-1158.
  20. Kawai K., Yoshizawa K., Fujie M., Kobayashi H., Ogawa Y., Yajima T. Use of fentanyl patch for treatment of moderate-to-severe chronic noncancer pain: Postmarketing surveillance of medical practice in Japan using a risk minimization action plan. Pain Practice, Volume 17(2), 2017: 239-248.
  21. Agarwal S., Polydefkis M., Block B., Haythornthwaite J., Raja S.N. Transdermal fentanyl reduces pain and improves functional activity in neuropathic pain states. Pain Medicine; 2007. №8(7): 554-562.
  22. Mordarski S., Lysenko L., Gerber H., Zietek M., Gredes T., Dominiak M. The effect of treatment with fentanyl patches on pain relief and improvement in overall daily functioning in patients with postherpetic neuralgia. J Physiol Pharmacol; 2009.№60(8):31-35.
  23. Ohtori S., Inoue G., Orita S., Eguchi Y., Ochiai N., Kishida S., Takaso M., Aoki Y., Kuniyoshi K., Nakamura J., Ishikawa T., Arai G., Miyagi M., Kamoda H., Suzuki M., Toyone T., Takahashi K. Transdermal fentanyl for chronic low back pain. Yonsei Med J; 2012. - 53(4):788-793.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##